Resultados de procura - Minna Balbas
- Mostrando 1 - 8 Resultados de 8
-
1
Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis por Neil P. Shah, Corynn Kasap, Christopher Weier, Minna Balbas, John Nicoll, Eric Bleickardt, Claude Nicaise, Charles L. Sawyers
Publicado 2008Artigo -
2
-
3
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor por Philip A. Watson, Yinan F. Chen, Minna Balbas, John Wongvipat, Nicholas D. Socci, Agnès Viale, Kwanghee Kim, Charles L. Sawyers
Publicado 2010Artigo -
4
-
5
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade por Vivek Arora, Emily Schenkein, Rajmohan Murali, Sumit K. Subudhi, John Wongvipat, Minna Balbas, Neel Shah, Ling Cai, Eleni Efstathiou, Chris Logothetis, Deyou Zheng, Charles L. Sawyers
Publicado 2013Artigo -
6
Genomic Evolution and Resistance during Pirtobrutinib Therapy in Covalent BTK-Inhibitor (cBTKi) Pre-Treated Chronic Lymphocytic Leukemia Patients: Updated Analysis from the BRUIN S... por Jennifer R. Brown, Sai Prasad Desikan, Bastien Nguyen, Helen Won, Shady I. Tantawy, Samuel McNeely, Narasimha Marella, Kevin Ebata, Jennifer A. Woyach, Krish Patel, Constantine S. Tam, Toby A. Eyre, Chan Y. Cheah, Nirav N. Shah, Paolo Ghia, Wojciech Jurczak, Minna Balbas, Binoj C. Nair, Paolo Abada, Chunxiao Wang, Ying Wang, Lindsey E. Roeker, Varsha Gandhi, William G. Wierda
Publicado 2023Artigo -
7
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma por Michael Wang, Wojciech Jurczak, Pier Luigi Zinzani, Toby A. Eyre, Chan Y. Cheah, Chaitra S. Ujjani, Youngil Koh, Koji Izutsu, James N. Gerson, Ian W. Flinn, Benoît Tessoulin, Alvaro J. Alencar, Shuo Ma, David John Lewis, Ewa Lech‐Marańda, Joanna Rhodes, Krish Patel, Kami J. Maddocks, Nicole Lamanna, Yucai Wang, Constantine S. Tam, Talha Munir, Hirokazu Nagai, Francisco J. Hernandez‐Ilizaliturri, Anita Kumar, Timothy S. Fenske, John F. Seymour, Andrew D. Zelenetz, Binoj C. Nair, Donald E. Tsai, Minna Balbas, Richard A. Walgren, Paolo Abada, Chunxiao Wang, Junjie Zhao, Anthony R. Mato, Nirav N. Shah
Publicado 2023Artigo -
8
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia por Anthony R. Mato, Jennifer A. Woyach, Jennifer R. Brown, Paolo Ghia, Krish Patel, Toby A. Eyre, Talha Munir, Ewa Lech‐Marańda, Nicole Lamanna, Constantine S. Tam, Nirav N. Shah, Catherine C. Coombs, Chaitra S. Ujjani, Bita Fakhri, Chan Y. Cheah, Manish R. Patel, Alvaro J. Alencar, Jonathon B. Cohen, James N. Gerson, Ian W. Flinn, Shuo Ma, Deepa Jagadeesh, Joanna Rhodes, Francisco J. Hernandez‐Ilizaliturri, Pier Luigi Zinzani, John F. Seymour, Minna Balbas, Binoj C. Nair, Paolo Abada, Chunxiao Wang, Amy S. Ruppert, Denise Wang, Donald E. Tsai, William G. Wierda, Wojciech Jurczak
Publicado 2023Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Cancer research
Internal medicine
Biology
Genetics
Pharmacology
Androgen receptor
Cancer
Chemistry
Endocrinology
Gene
Prostate cancer
Receptor
Androgen
Antiandrogens
Biochemistry
Bruton's tyrosine kinase
Chronic lymphocytic leukemia
Clinical endpoint
Clinical trial
Enzalutamide
Gastroenterology
Gene expression
Hormone
Immunology
Leukemia
Transcription factor
Tyrosine kinase
Adverse effect
Agonist